Fresenius Medical Care AG (FME)

Add to research

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance
Add to research
View more

Current Price

as of Mar 13, 2025

$46.45

P/E Ratio

23.32

Market Cap

$13.65B

Loading...
Description
Add to research
View more

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Metrics
Add to research
View more

Overview

  • HQBad Homburg, HE
  • SectorHealth Services
  • IndustryMedical/Nursing Services
  • TickerFME
  • Price$46.454967-4.09%

Trading Information

  • Market cap$13.65B
  • Float71.45%
  • Average Daily Volume (1m)688,968
  • Average Daily Volume (3m)593,141
  • EPS$1.83

Company

  • Revenue$19.34B
  • Rev growth (1yr)-0.60%
  • Net income$537.91M
  • Gross margin24.63%
  • EBITDA margin16.44%
  • EBITDA$3.18B
  • EV$23.80B
  • EV/Revenue1.23
  • P/E23.32
  • P/S0.65
  • P/B0.86
  • Debt/Equity75.32
Documents
Add to research
View more